Gaspar, P;
Cohen, H;
Isenberg, DA;
(2020)
The assessment of patients with the antiphospholipid antibody syndrome: where are we now?
Rheumatology
, 59
(7)
pp. 1489-1494.
10.1093/rheumatology/keaa172.
Preview |
Text
Isenberg_The Assessment of Patients with APS_V3_submitedVersion_CLEAN COPY 27.1.2020.pdf - Accepted Version Download (333kB) | Preview |
Abstract
The antiphospholipid antibody syndrome (APS), a chronic autoimmune thrombophilia with an increased mortality and morbidity, has been recognized for more than three decades. Unlike other autoimmune rheumatic conditions such as systemic lupus erythematosus, myositis and Sjögren’s syndrome, relatively few attempts have been made to develop activity, damage or disease-specific quality of life indices for APS. In this review of the literature, we consider those attempts that have been made to develop assessment tools for patients with APS, but also reflect upon the nature of the condition, to discuss, in particular, whether an activity index is appropriate for this disease.
Archive Staff Only
 |
View Item |
